Carcinoma of the Prostate

Abstract

Use of irradiation as an adjuvant to radical surgical treatment of prostatic cancer, with or without lymphadenectomy, has been associated with definite improvement of mortality and morbidity. Hormonal therapy and bilateral orchiectomy also can be used as adjuvants to surgery and irradiation. Endocrine therapy has not proved curative but has definite value. When relapse occurs after orchiectomy and estrogen therapy, technics to alter adrenal function seem to be of value. Chemotherapy and generalized irradiation are helpful in palliation and seem to have exciting potentials.